Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PLATELET RECOVERY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 196 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Gazitt, Y
      Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Van den Oudenrijn, S; Von dem Borne, AEGK; de Haas, M
      Influence of medium components on ex vivo megakaryocyte expansion

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    3. Gazitt, Y; Shaughnessy, P; Liu, Q
      Expression of adhesion molecules on CD34(+) cells in peripheral blood of non-Hodgkin's lymphoma patients mobilized with different growth factors

      STEM CELLS
    4. Shimizu, Y; Utsugi, K; Umezawa, S; Shimizu, K; Hasumi, K; Suzuki, M; Takaku, F
      Effect of human urinary macrophage colony-stimulating factor on the immunefunctions and the blood cell counts in patients with ovarian carcinoma receiving cytotoxic chemotherapy

      ONCOLOGY REPORTS
    5. Menendez, P; del Canizo, MC; Orfao, A
      Immunophenotypic characteristics of PB-mobilised CD34(+) hematopoietic progenitor cells

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    6. Borbolla, JR; Lopez-Hernandez, MA; DeDiego, J; Gonzalez-Avante, M; Trueba, E; Collados, MT
      Use of interleukin-11 after autologous stem cell transplant: report of three cases and a very brief review of the literature

      HAEMATOLOGICA
    7. Hattori, Y; Kato, H; Nitta, M; Takamoto, S
      Decrease of L-selectin expression on human CD34(+) cells on freeze-thawingand rapid recovery with short-term incubation

      EXPERIMENTAL HEMATOLOGY
    8. Pecora, AL; Stiff, P; LeMaistre, CF; Bayer, R; Bachier, C; Goldberg, SL; Parthasarathy, M; Jennis, AA; Smith, AK; Douville, J; Chen, B; Armstrong, RD; Mandalam, RK; Preti, R
      A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation

      BONE MARROW TRANSPLANTATION
    9. Wolff, SN; Herzig, R; Lynch, J; Ericson, SG; Greer, JP; Stein, R; Goodman, S; Benyunes, MC; Ashby, M; Jones, DV; Fay, J
      Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study

      BONE MARROW TRANSPLANTATION
    10. Filip, S; Blaha, M; Petera, J; Vavrova, J; Knizek, J
      Peripheral progenitor cells (PBPC) in supportive care after high-dose chemotherapy in breast cancer

      NEOPLASMA
    11. Pratt, G; Rawstron, AC; English, AE; Johnson, RJ; Jack, AS; Morgan, GJ; Smith, GM
      Analysis of CD34(+) cell subsets in stem cell harvests can more reliably predict rapidity and durability of engraftment than total CD34(+) cell dose,but steady state levels do not correlate with bone marrow reserve

      BRITISH JOURNAL OF HAEMATOLOGY
    12. Desikan, KR; Tricot, G; Munshi, NC; Anaissie, E; Spoon, D; Fassas, A; Toor, A; Zangari, M; Badros, A; Morris, C; Vesole, DH; Siegel, D; Jagannath, S; Barlogie, B
      Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone

      BRITISH JOURNAL OF HAEMATOLOGY
    13. Szilvassy, SJ; Meyerrose, TE; Ragland, PL; Grimes, B
      Differential homing and engraftment properties of hematopoietic progenitorcells from murine bone marrow, mobilized peripheral blood, and fetal liver

      BLOOD
    14. Schwartz, JM; Wolford, JL; Thornquist, MD; Hockenbery, DM; Murakami, CS; Drennan, F; Hinds, M; Strasser, SI; Lopez-Cubero, SO; Brar, HS; Ko, CW; Saunders, MD; Okolo, CN; McDonald, GB
      Severe gastrointestinal bleeding after hematopoietic cell transplantation,1987-1997: Incidence, causes, and outcome

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    15. Lefebvre, P; Winter, JN; Meng, YR; Cohen, I
      Ex vivo expansion of early and late megakaryocyte progenitors

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    16. Kroger, N; Kruger, W; Renges, H; Zeller, W; Rauhoft, C; Loliger, C; Zander, AR
      Comparison of progenitor cell collection on day 4 or day 5 after steady-state stimulation with G-CSF alone in breast cancer patients: Influence on CD34(+) cell yield, subpopulation, and breast cancer cell contamination

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    17. Stockerl-Goldstein, KE; Reddy, SA; Horning, SJ; Blume, KG; Chao, NJ; Hu, WW; Johnston, LJ; Long, GD; Strober, S; Wong, RM; Feiner, RH; Kohler, S; Negrin, RS
      Favorable treatment outcome in non-Hodgkin's lymphoma patients with "poor"mobilization of peripheral blood progenitor cells

      BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
    18. Baech, J; Johnsen, HE
      Technical aspects and clinical impact of hematopoietic progenitor subset quantification

      STEM CELLS
    19. Halle, P; Rouzier, C; Kanold, J; Boiret, N; Rapatel, C; Mareynat, G; Tchirkov, A; Berger, M; Travade, P; Bonhomme, J; Demeocq, F
      Ex vivo expansion of CD34+/CD41+late progenitors from enriched peripheral blood CD34+cells

      ANNALS OF HEMATOLOGY
    20. Nagahama, M; Nomura, S; Katsura, K; Ozaki, Y; Yoshimura, C; Kagawa, H; Fukuhara, S
      Serum levels of soluble CD30 in autologous peripheral blood stem cell transplantation

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    21. Kanold, J; Yakouben, K; Tchirkov, A; Carret, AS; Vannier, JP; LeGall, E; Bordigoni, P; Demeocq, F
      Long-term results of CD34(+) cell transplantation in children with neuroblastoma

      MEDICAL AND PEDIATRIC ONCOLOGY
    22. Dimitroff, CJ; Lee, JY; Fuhlbrigge, RC; Sackstein, R
      A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    23. Milone, GA; Rolon, JM; Fernandez, II; Corrado, CS; Desmery, PM; Dignani, MC; Juni, M; Pavlovsky, S
      Eight years of autologous progenitor cell transplantation in patients withhematological diseases and solid tumors in a single institution.

      MEDICINA-BUENOS AIRES
    24. van Hennik, PB; Breems, DA; Kusadasi, N; Slaper-Cortenbach, ICM; van den Berg, H; van der Lelie, HJ; Schipperus, MR; Cornelissen, JJ; Ploemacher, RE
      Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation

      BRITISH JOURNAL OF HAEMATOLOGY
    25. Drayer, AL; Sibinga, CTS; Blom, NR; de Wolf, JTM; Vellenga, E
      The in vitro effects of cytokines on expansion and migration of megakaryocyte progenitors

      BRITISH JOURNAL OF HAEMATOLOGY
    26. Orschell-Traycoff, CM; Hiatt, K; Dagher, RN; Rice, S; Yoder, MC; Srour, EF
      Homing and engraftment potential of Sca-1(+)lin(-) cells fractionated on the basis of adhesion molecule expression and position in cell cycle

      BLOOD
    27. Liu, FL; Poursine-Laurent, J; Link, DC
      Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF

      BLOOD
    28. Surbek, DV; Steinmann, C; Burk, M; Hahn, S; Tichelli, A; Holzgreve, W
      Developmental changes in adhesion molecule expressions in umbilical cord blood CD34(+) hematopoietic progenitor and stem cells

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    29. Waller, EK; Barlett, N; Chen, CH; Mujic, V; Sussman, H; Toepker, S; Grenier, K
      Variations in the content of CD34(+) cells in the peripheral blood of cancer patients receiving out-patient chemotherapy

      CYTOTHERAPY
    30. De Waele, M; Renmans, W; Jochmans, K; Schots, R; Lacor, P; Trullemans, F; Otten, J; Balduck, N; Vander Gucht, K; Van Camp, B; Van Riet, I
      Different expression of adhesion molecules on CD34(+) cells in AML and B-lineage ALL and their normal bone marrow counterparts

      EUROPEAN JOURNAL OF HAEMATOLOGY
    31. del Canizo, MC; Lopez, N; Vazquez, L; Fernandez, ME; Brufau, A; Caballero, MD; Amigo, ML; Mateos, MV; Gutierrez, N; San Miguel, J
      Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery

      HAEMATOLOGICA
    32. Sautois, B; Fraipont, V; Baudoux, E; Fassotte, MF; Hermanne, JP; Jerusalem, G; Bours, V; Bosquee, L; Schaaf-Lafontaine, N; Paulus, JM; Sondag, D; Fillet, G; Beguin, Y
      Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields

      HAEMATOLOGICA
    33. Narabayashi, M; Takeyama, K; Fukutomi, T; Tokuda, Y; Tajima, T; Okumura, A; Chou, T; Sano, M; Makino, H; Igarashi, T; Sasaki, Y; Imoto, S; Ogura, M; Morishima, Y; Murai, H; Okamoto, S; Ikeda, T; Kasai, M; Yokozawa, T; Tobinai, K
      A dose-finding study of lenograstim (glycosylated rHuG-CSF) for peripheralblood stem cell mobilization during postoperative adjuvant chemotherapy inpatients with breast cancer

      JAPANESE JOURNAL OF CLINICAL ONCOLOGY
    34. MacVittie, TJ; Farese, AM; Davis, TA; Lind, LB; McKearn, JP
      Myelopoietin, a chimeric agonist of human interleukin 3 and granulocyte colony-stimulating factor receptors, mobilizes CD34(+) cells that rapidly engraft lethally x-irradiated nonhuman primates

      EXPERIMENTAL HEMATOLOGY
    35. Benedetti, G; Patoia, L; Giglietti, A; Alessio, M; Pelicci, PG; Grignani, F
      Very large amounts of peripheral blood progenitor cells eliminate severe thrombocytopenia after high-dose melphalan in advanced breast cancer patients

      BONE MARROW TRANSPLANTATION
    36. Venditti, A; Battaglia, A; Del Poeta, G; Buccisano, F; Maurillo, L; Tamburini, A; Del Moro, B; Epiceno, AM; Martiradonna, M; Caravita, T; Santinelli, S; Adorno, G; Picardi, A; Zinno, F; Lanti, A; Bruno, A; Suppo, G; Franchi, A; Franconi, G; Amadori, S
      Enumeration of CD34(+) hematopoietic progenitor cells for clinical transplantation: comparison of three different methods

      BONE MARROW TRANSPLANTATION
    37. de la Rubia, J; Martinez, C; Solano, C; Brunet, S; Cascon, P; Arrieta, R; Alegre, A; Bargay, J; de Arriba, F; Canizo, C; Lopez, J; Serrano, D; Verdeguer, A; Torrabadella, M; Diaz, MA; Insunza, A; de la Serna, J; Espigado, I; Petit, J; Martinez, M; Benlloch, L; Sanz, MA
      Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry

      BONE MARROW TRANSPLANTATION
    38. Damiani, D; Grimaz, S; Infanti, L; Sperotto, A; Silvestri, F; Geromin, A; Cerno, M; Savignano, C; Michieli, M; Skert, C; Fanin, R; Baccarani, M
      Autologous bone marrow transplantation in non-Hodgkin's lymphoma patients:effect of a brief course of G-CSF on harvest and recovery

      BONE MARROW TRANSPLANTATION
    39. D'Hondt, L; Wuu, J; Andre, M; van Lerberghe, C; Guillaume, T; Feyens, AM; Humblet, Y; Dromelet, A; Chatelain, B; Longueville, J; Stewart, FM; D'Hondt, V; Symann, M
      Clearance kinetics of CD34(+) cells from peripheral blood: an independent predictor of hematologic recovery after high-dose chemotherapy and hematopoietic stem cell transplantation

      BONE MARROW TRANSPLANTATION
    40. Maharaj, D; Steinberg, JP; Gouvea, JV; Gieser, PW
      Changes in endogenous TPO levels during mobilization chemotherapy are predictive of CD34(+) megakaryocyte progenitor yield and identify patients at risk of delayed platelet engraftment post-PBPC transplant

      BONE MARROW TRANSPLANTATION
    41. Kroger, N; Zeller, W; Hassan, HT; Kruger, W; Gutensohn, K; Loliger, C; Zander, AR
      Stem cell mobilization with G-CSF alone in breast cancer patients: higher progenitor cell yield by delivering divided doses (2x5 mu g/kg) compared toa single dose (1x10 mu g/kg)

      BONE MARROW TRANSPLANTATION
    42. Pecora, AL
      Impact of stem cell dose on hematopoietic recovery in autologous blood stem cell recipients

      BONE MARROW TRANSPLANTATION
    43. Mori, T; Nakamura, M; Shimizu, K; Ikeda, Y; Ando, K
      In vivo disturbance of hematopoiesis in mice persistently infected with murine cytomegalovirus: Impairment of stromal cell function

      VIROLOGY
    44. Levin, MD; de Vries, W; de Veld, J; Doekharan, D; van der Holt, B; van't Veer, MB
      Platelet-bound immunoglobulins before and after platelet transfusion: measurement of in vivo binding

      BRITISH JOURNAL OF HAEMATOLOGY
    45. CAO XT; CAI R; JU DW; TAO Q; YU YZ; WANG JL
      AUGMENTATION OF HEMATOPOIESIS BY FIBROBLAST-MEDIATED INTERLEUKIN-6 GENE-THERAPY IN MICE WITH CHEMOTHERAPY

      Journal of interferon & cytokine research
    46. HUSSEIN MA; FLETCHER R; LONG TJ; ZUCCARO K; BOLWELL BJ; HOELTGE GA
      TRANSFUSING PLATELETS 2H AFTER THE COMPLETION OF AMPHOTERICIN-B DECREASES ITS DETRIMENTAL EFFECT ON TRANSFUSED PLATELET RECOVERY AND SURVIVAL

      TRANSFUSION MEDICINE
    47. KROGER N; ZELLER W; HASSAN HT; KRUGER W; RENGES H; HUMMEL K; GUTENSOHN K; LOLLIGER C; ZANDER AR
      SUCCESSFUL MOBILIZATION OF PERIPHERAL-BLOOD STEM-CELLS IN HEAVILY PRETREATED MYELOMA PATIENTS WITH G-CSF ALONE

      Annals of hematology
    48. BOJKO P; HESTER JP; DURETT AG; MAADANI F; KORBLING M; CHAMPLIN RE
      IDENTIFICATION OF MEGAKARYOCYTE PRECURSORS IN PERIPHERAL-BLOOD STEM-CELL COLLECTIONS FROM NORMAL DONORS

      Journal of clinical apheresis
    49. PECORA AL; PRETI RA; GLEIM GW; JENNIS A; ZAHOS K; CANTWELL S; DORIA L; ISAACS R; GILLIO AP; MICHELIS MA; BROCHSTEIN JA
      CD34(-) CELLS INFLUENCE DAYS TO ENGRAFTMENT AND TRANSFUSION REQUIREMENTS IN AUTOLOGOUS BLOOD STEM-CELL RECIPIENTS()CD33()

      Journal of clinical oncology
    50. DESIKAN KR; BARLOGIE B; JAGANNATH S; VESOLE DH; SIEGEL D; FASSAS A; MUNSHI N; SINGHAL S; MEHTA J; TINDLE S; NELSON J; BRACY D; MATTOX S; TRICOT G
      COMPARABLE ENGRAFTMENT KINETICS FOLLOWING PERIPHERAL-BLOOD STEM-CELL INFUSION MOBILIZED WITH GRANULOCYTE-COLONY-STIMULATING FACTOR WITH OR WITHOUT CYCLOPHOSPHAMIDE IN MULTIPLE-MYELOMA

      Journal of clinical oncology
    51. IMBERT AM; BAGNIS C; GALINDO R; CHABANNON C; MANNONI P
      A NEUTRALIZING ANTI-TGF-BETA-1 ANTIBODY PROMOTES PROLIFERATION OF CD34(-1(+) PERIPHERAL-BLOOD PROGENITORS AND INCREASES THE NUMBER OF TRANSDUCED PROGENITORS()THY)

      Experimental hematology
    52. LOWENTHAL RM; FABERES C; MARIT G; BOIRON JM; CONYMAKHOUL P; PIGNEUX A; AGAPE P; VEZON G; BOUZGAROU R; DAZEY B; FIZET D; BERNARD P; LACOMBE F; REIFFERS J
      FACTORS INFLUENCING HEMATOPOIETIC RECOVERY FOLLOWING CHEMOTHERAPY-MOBILIZED AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION FORHEMATOLOGICAL MALIGNANCIES - A RETROSPECTIVE ANALYSIS OF A 10-YEAR SINGLE INSTITUTION EXPERIENCE

      Bone marrow transplantation
    53. MILLAR BC; MILLAR JL; SHEPHERD V; BLACKWELL P; PORTER H; CUNNINGHAM D; JUDSON I; TRELEAVEN J; POWLES RL; CATOVSKY D
      THE IMPORTANCE OF CD34(+) CD33(-) CELLS IN PLATELET ENGRAFTMENT AFTERINTENSIVE THERAPY FOR CANCER-PATIENTS GIVEN PERIPHERAL-BLOOD STEM-CELL RESCUE/

      Bone marrow transplantation
    54. BOLWELL BJ; POHLMAN B; ANDRESEN S; KALAYCIO M; GOORMASTIC M; WISE K; WAKELING A; DANNLEY R; OVERMOYER B
      DELAYED G-CSF AFTER AUTOLOGOUS PROGENITOR-CELL TRANSPLANTATION - A PROSPECTIVE RANDOMIZED TRIAL

      Bone marrow transplantation
    55. TARELLA C; CASTELLINO C; LOCATELLI F; CARACCIOLO D; CORRADINI P; FALDA M; NOVARINO A; TASSI V; PILERI A
      G-CSF ADMINISTRATION FOLLOWING PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) AUTOGRAFT IN LYMPHOID MALIGNANCIES - EVIDENCE FOR CLINICAL BENEFITS AND REDUCTION OF TREATMENT COSTS

      Bone marrow transplantation
    56. FENG R; SHIMAZAKI C; INABA T; TAKAHASHI R; HIRAI H; KIKUTA T; SUMIKUMA T; YAMAGATA N; ASHIHARA E; FUJITA N; NAKAGAWA M
      CD34(+) CD41(+) CELLS BEST PREDICT PLATELET RECOVERY AFTER AUTOLOGOUSPERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION/

      Bone marrow transplantation
    57. Bielski, M; Yomtovian, R; Lazarus, HM; Rosenthal, N
      Prolonged isolated thrombocytopenia after hematopoietic stem cell transplantation: morphologic correlation

      BONE MARROW TRANSPLANTATION
    58. Koenigsmann, MP; Koenigsmann, M; Notter, M; Neuloh, M; Mucke, C; Thiel, E; Berdel, WE
      Adhesion molecules on peripheral blood-derived CD34(+) cells: effects of cryopreservation and short-term ex vivo incubation with serum and cytokines

      BONE MARROW TRANSPLANTATION
    59. Zambelli, A; Poggi, G; Da Prada, G; Pedrazzoli, P; Cuomo, A; Miotti, D; Perotti, C; Preti, P; Della Cuna, GR
      Clinical toxicity of cryopreserved circulating progenitor cells infusion

      ANTICANCER RESEARCH
    60. Katsura, K; Nomura, S; Ohtani, T; Matsumoto, N; Shimizu, T; Yamaguchi, K; Kishimoto, Y; Kitajima, H; Fukuhara, S
      Changes of immunological markers after autologous peripheral blood stem cell transplantation

      JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
    61. WAGEMAKER G
      IN-VITRO AND IN-VIVO EXPANSION OF STEM-CELL POPULATIONS

      Vox sanguinis
    62. PROSPER F; STRONCEK D; MCCARTHY JB; VERFAILLIE CM
      MOBILIZATION AND HOMING OF PERIPHERAL-BLOOD PROGENITORS IS RELATED TOREVERSIBLE DOWN-REGULATION OF ALPHA-4-BETA-1 INTEGRIN EXPRESSION AND FUNCTION

      The Journal of clinical investigation
    63. HENON P; SOVALAT H; BECKER M; ARKAM Y; OJEDAURIBE M; RAIDOT JP; HUSSEINI F; WUNDER E; BOUDERONT D; AUDHUY B
      PRIMORDIAL ROLE OF CD34(-) CELLS IN EARLY AND LATE TRILINEAGE HEMATOPOIETIC ENGRAFTMENT AFTER AUTOLOGOUS BLOOD-CELL TRANSPLANTATION()38()

      British Journal of Haematology
    64. KROGER N; ZELLER W; FEHSE N; HASSAN HT; KRUGER W; GUTENSOHN K; LOLLIGER C; ZANDER AR
      MOBILIZING PERIPHERAL-BLOOD STEM-CELLS WITH HIGH-DOSE G-CSF ALONE IS AS EFFECTIVE AS WITH DEXA-BEAM PLUS G-CSF IN LYMPHOMA PATIENTS

      British Journal of Haematology
    65. TAKAMATSU Y; SIMMONS PJ; MOORE RJ; MORRIS HA; TO LB; LEVESQUE JP
      OSTEOCLAST-MEDIATED BONE-RESORPTION IS STIMULATED DURING SHORT-TERM ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR BUT IS NOT RESPONSIBLE FOR HEMATOPOIETIC PROGENITOR-CELL MOBILIZATION

      Blood
    66. YAMAGUCHI M; IKEBUCHI K; HIRAYAMA F; SATO N; MOGI Y; OHKAWARA J; YOSHIKAWA Y; SAWADA K; KOIKE T; SEKIGUCHI S
      DIFFERENT ADHESIVE CHARACTERISTICS AND VLA-4 EXPRESSION OF CD34(+) PROGENITORS IN G(0) G(1) VERSUS S+G(2)/M PHASES OF THE CELL-CYCLE/

      Blood
    67. HERMOUET S; NIAUSSAT AE; BRIEC A; PINEAU D; ROBILLARD N; BATAILLE R; MILPIED N; HAROUSSEAU JL; MAHE B
      ANALYSIS OF PLATELET RECOVERY AFTER AUTOLOGOUS TRANSPLANTATION WITH G-CSF MOBILIZED CD34+ CELLS PURIFIED FROM LEUKAPHERESIS PRODUCTS

      HEMATOLOGY AND CELL THERAPY
    68. LECORROLLER AG; FAUCHER C; AUPERIN A; BLAISE D; FORTANIER C; BENHAMOU E; HARTMANN O; BROSSE JC; MARANINCHI D; MOATTI JP
      AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION VERSUS AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR ADULTS AND CHILDREN WITH NONLEUKEMIC MALIGNANT DISEASE - A RANDOMIZED ECONOMIC-STUDY

      PharmacoEconomics
    69. MOORE MAS
      STEM-CELL PROLIFERATION - EX-VIVO AND IN-VIVO OBSERVATIONS

      Stem cells
    70. LAZARUS HM; HAYNESWORTH SE; GERSON SL; CAPLAN AI
      HUMAN BONE-MARROW-DERIVED MESENCHYMAL (STROMAL) PROGENITOR CELLS (MPCS) CANNOT BE RECOVERED FROM PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS

      Journal of hematotherapy
    71. ROBERTS AW; GRIGG AP
      OPTIMAL REGIMENS FOR THE MOBILIZATION AND COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS FROM NORMAL DONORS

      Leukemia & lymphoma
    72. HASSAN HT; KROG C; STOCKSCHLADER M; ZELLER W; KRUGER W; ERTTMANN R; ZANDER AR
      FACTORS INFLUENCING HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE

      Supportive care in cancer
    73. SINGHAL S; POWLES R; TRELEAVEN J; HORTON C; PINKERTON CR; MELLER S; MEHTA J
      CYTOMEGALOVIREMIA AFTER AUTOGRAFTING FOR LEUKEMIA - CLINICAL-SIGNIFICANCE AND LACK OF EFFECT ON ENGRAFTMENT

      Leukemia
    74. WANG JB; MUKAIDA N; ZHANG Y; ITO T; NAKAO S; MATSUSHIMA K
      ENHANCED MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS BY MOUSE MIP-2 AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN MICE

      Journal of leukocyte biology
    75. TABBARA IA; GHAZAL CD; GHAZAL HH
      THE ROLE OF GRANULOCYTE-COLONY-STIMULATING FACTOR IN HEMATOPOIETIC STEM-CELL TRANSPLANTATION

      Cancer investigation
    76. VOSE JM; PANDITE AN; BEVERIDGE RA; GELLER RB; SCHUSTER MW; ANDERSON JE; LEMAISTRE CF; AHMED T; GRANENA A; KEATING A; RANADA JMF; STIFF PJ; TABBARA I; LONGO W; COPELAN EA; NICHOLS C; SMITH A; TOPOLSKY DL; BIERMAN PJ; LEBSACK ME; LANGE M; GARRISON L
      GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INTERLEUKIN-3 FUSIONPROTEIN VERSUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTERAUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA - RESULTS OF A RANDOMIZED DOUBLE-BLIND TRIAL

      Journal of clinical oncology
    77. COPELAN EA; CESELSKI SK; EZZONE SA; LASKY LC; PENZA SL; BECHTEL TP; KLEIN JL; HEHMEYER DM; SCHOLL MD; MARSHALL DD; ELDER PJ; RISLEY GL; AVALOS BR
      MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS WITH HIGH-DOSE ETOPOSIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN PATIENTS WITH BREAST-CANCER, NON-HODGKINS-LYMPHOMA, AND HODGKINS-DISEASE

      Journal of clinical oncology
    78. NEELIS KJ; DUBBELMAN YD; WOGNUM AW; THOMAS GR; EATON DL; EGELAND T; WAGEMAKER G
      LACK OF EFFICACY OF THROMBOPOIETIN AND GRANULOCYTE-COLONY-STIMULATINGFACTOR AFTER HIGH-DOSE TOTAL-BODY IRRADIATION AND AUTOLOGOUS STEM-CELL OR BONE-MARROW TRANSPLANTATION IN RHESUS-MONKEYS

      Experimental hematology
    79. FORTANIER C; MANNONICHAINE G; MOATTI JP
      BONE-MARROW TRANSPLANTATION TO CELL THERA PIES - NEW FORMS OF COOPERATION BETWEEN MEDICINE AND INDUSTRIAL FIRMS

      Sciences sociales et sante
    80. SPITZER G; ADKINS D; MATHEWS M; VELASQUEZ W; BOWERS C; DUNPHY F; KRONMUELLER N; NIEMEYER R; MCINTYRE W; PETRUSKA P
      RANDOMIZED COMPARISON OF G-CSF-CSF VS G-CSF ALONE FOR MOBILIZATION OFPERIPHERAL-BLOOD STEM-CELLS - EFFECTS ON HEMATOPOIETIC RECOVERY AFTERHIGH-DOSE CHEMOTHERAPY(GM)

      Bone marrow transplantation
    81. BEARMAN SI; OVERMOYER BA; BOLWELL BJ; TAYLOR CW; SHPALL EJ; CAGNONI PJ; MECHLING BE; RONK B; BARON AE; PURDY MH; ROSS M; JONES RB
      HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT FOR PRIMARY BREAST-CANCER IN PATIENTS WITH 4-9 INVOLVED AXILLARY LYMPH-NODES

      Bone marrow transplantation
    82. KISS JE; RYBKA WB; WINKELSTEIN A; DEMAGALHAESSILVERMAN M; LISTER J; DANDREA P; BALL ED
      RELATIONSHIP OF CD34(-BLOOD STEM-CELL TRANSPLANTATION() CELL DOSE TO EARLY AND LATE HEMATOPOIESIS FOLLOWING AUTOLOGOUS PERIPHERAL)

      Bone marrow transplantation
    83. HASSAN HT; KROG C; STOCKSCHLADER M; SCHLEIMER B; ZELLER W; KRUGER W; ERTTMANN R; ZANDER AR
      FACTORS INFLUENCING THE HEMATOLOGICAL RECOVERY AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION IN LEUKEMIA PATIENTS TREATED WITH METHOTREXATE-CONTAINING GVHD PROPHYLAXIS - A SINGLE-CENTER EXPERIENCE

      Anticancer research
    84. WEAVER CH; SCHWARTZBERG LS; BIRCH R; GRECO FA; RHINEHART S; HAINSWORTH J; BEEKER T; PRICE H; GEIER L; FOSTER J; WEST J; HAZELTON B; BUCKNER CD
      COLLECTION OF PERIPHERAL-BLOOD PROGENITOR CELLS AFTER THE ADMINISTRATION OF CYCLOPHOSPHAMIDE, ETOPOSIDE, AND GRANULOCYTE-COLONY-STIMULATINGFACTOR - AN ANALYSIS OF 497 PATIENTS

      Transfusion
    85. STRONCEK DF; CLAY ME; SMITH J; HERR G; ILSTRUP S; KUNKEL LA; MCCULLOUGH J
      COMPOSITION OF PERIPHERAL-BLOOD PROGENITOR-CELL COMPONENTS COLLECTED FROM HEALTHY DONORS

      Transfusion
    86. AIUTI A; WEBB IJ; BLEUL C; SPRINGER T; GUTIERREZRAMOS JC
      THE CHEMOKINE SDF-1 IS A CHEMOATTRACTANT FOR HUMAN CD34(-BLOOD() HEMATOPOIETIC PROGENITOR CELLS AND PROVIDES A NEW MECHANISM TO EXPLAIN THEMOBILIZATION OF CD34(+) PROGENITORS TO PERIPHERAL)

      The Journal of experimental medicine
    87. KWEKKEBOOM J; BUURMAN DEP; VANHENNIK PB; PLOEMACHER RE; LOOS HA; SLAPERCORTENBACH ICM
      SEPARATION OF G-CSF-MOBILIZED PBSC TRANSPLANTS BY COUNTERFLOW CENTRIFUGAL ELUTRIATION - MODEST ENRICHMENT OF CD34(+) CELLS BUT NO LOSS OF PRIMITIVE HEMATOPOIETIC PROGENITORS

      British Journal of Haematology
    88. PEDRAZZOLI P; PEROTTI C; DAPRADA GA; BERTOLINI F; GIBELLI N; TORRETTA L; BATTAGLIA M; PAVESI L; PRETI P; SALVANESCHI L; DELLACUNA GR
      COLLECTION OF CIRCULATING PROGENITOR CELLS AFTER EPIRUBICIN, PACLITAXEL AND FILGRASTIM IN PATIENTS WITH METASTATIC BREAST-CANCER

      British Journal of Cancer
    89. PANICI PB; PIERELLI L; SCAMBIA G; FODDAI ML; SALERNO MG; MENICHELLA G; VITTORI M; MANESCHI F; CARACUSSI U; SERAFINI R; LEONE G; MANCUSO S
      HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND MELPHALAN (CEM) WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT AS LATE INTENSIFICATION FOR HIGH-RISK CANCER - NONHEMATOLOGICAL, HEMATOLOGICAL TOXICITIES AND ROLE OF GROWTH-FACTOR ADMINISTRATION

      British Journal of Cancer
    90. NEELIS KJ; HARTONG SCC; EGELAND T; THOMAS GR; EATEN DL; WAGEMAKER G
      THE EFFICACY OF SINGLE-DOSE ADMINISTRATION OF THROMBOPOIETIN WITH COADMINISTRATION OF EITHER GRANULOCYTE MACROPHAGE OR GRANULOCYTE-COLONY-STIMULATING FACTOR IN MYELOSUPPRESSED RHESUS-MONKEYS/

      Blood
    91. ZHURAVSKAYA T; MACIEJEWSKI JP; NETSKI DM; BRUENING E; MACKINTOSH FR; STJEOR S
      SPREAD OF HUMAN CYTOMEGALOVIRUS (HCMV) AFTER INFECTION OF HUMAN HEMATOPOIETIC PROGENITOR CELLS - MODEL OF HCMV LATENCY

      Blood
    92. BEELEN DW; OTTINGER HD; ELMAAGACLI A; SCHEULEN B; BASU O; KREMENS B; HAVERS W; GROSSEWILDE H; SCHAEFER UW
      TRANSPLANTATION OF FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS FROM HLA-IDENTICAL SIBLING OR ALTERNATIVE FAMILY DONORS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES - A PROSPECTIVE COMPARISON ON CLINICAL OUTCOME, IMMUNE RECONSTITUTION, AND HEMATOPOIETIC CHIMERISM

      Blood
    93. DAMIANI D; FANIN R; SILVESTRI F; GRIMAZ S; INFANTI L; GEROMIN A; CERNO M; MICHIELI M; RINALDI C; SAVIGNANO C; TRANI G; FIACCHINI M; BACCARANI M
      RANDOMIZED TRIAL OF AUTOLOGOUS FILGRASTIM-PRIMED BONE-MARROW TRANSPLANTATION VERSUS FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN LYMPHOMA PATIENTS

      Blood
    94. BASSER RL; RASKO JEJ; CLARKE K; CEBON J; GREEN MD; GRIGG AP; ZALCBERG J; COHEN B; OBYRNE J; MENCHACA DM; FOX RM; BEGLEY CG
      RANDOMIZED, BLINDED, PLACEBO-CONTROLLED PHASE-I TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR WITH FILGRASTIM AFTER DOSE-INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER

      Blood
    95. KUSNIERZGLAZ CR; STILL BJ; AMANO M; ZUKOR JD; NEGRIN RS; BLUME KG; STROBER S
      GRANULOCYTE-COLONY-STIMULATING FACTOR-INDUCED COMOBILIZATION OF CD4(-)CD8(-) T-CELLS AND HEMATOPOIETIC PROGENITOR CELLS (CD34(+)) IN THE BLOOD OF NORMAL DONORS

      Blood
    96. SOMLO G; SNIECINSKI I; ODOMMARYON T; NOWICKI B; CHOW W; HAMASAKI V; LEONG L; MARGOLIN K; MORGAN R; RASCHKO J; SHIBATA S; TETEF M; MOLINA A; BERENSON RJ; FORMAN SJ; DOROSHOW JH
      EFFECT OF CD34(-CELL REINFUSION AND GRANULOCYTE-COLONY-STIMULATING FACTOR PRIMING ON HEMATOPOIETIC RECOVERY AFTER HIGH-DOSE CHEMOTHERAPY FOR BREAST-CANCER() SELECTION AND VARIOUS SCHEDULES OF STEM)

      Blood
    97. HARTMANN O; LECORROLLER AG; BLAISE D; MICHON J; PHILIP I; NOROL F; JANVIER M; PICO JL; BARANZELLI MC; RUBIE H; COZE C; PINNA A; MERESSE V; BENHAMOU E
      PERIPHERAL-BLOOD STEM-CELL AND BONE-MARROW TRANSPLANTATION FOR SOLID TUMORS AND LYMPHOMAS - HEMATOLOGIC RECOVERY AND COSTS - A RANDOMIZED, CONTROLLED TRIAL

      Annals of internal medicine
    98. SHERIDAN WP; TO LB; BROWN SL; GRIGG A; FOOTE MA; JUTTNER CA
      THE CLINICAL USE OF RHUG-CSF (FILGRASTIM)-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS FOR THE TRANSPLANTATION

      Journal of drug development and clinical practice
    99. KORBLING M; CHAMPLIN R
      PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION - A REPLACEMENT FOR MARROW AUTOGRAFTS OR ALLOGRAFTS

      Stem cells
    100. DIAZMEDIAVILLA J; LLORENTE L; MARTINEZ R; ALVAREZCARMONA A; JORDA J; DELPOTRO E; GONZALEZ A; MORALES D; ASENJO S; FARINAS M; SAEZ I; VILLEGAS A
      AUTOTRANSPLANTATION OF PERIPHERAL-BLOOD STEM-CELLS MOBILIZED BY G-CSFIN HEMATOLOGICAL MALIGNANCIES - EVIDENCE FOR RAPID AND LONG-TERM SUSTAINED HEMATOPOIETIC RECONSTITUTION

      Leukemia & lymphoma


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 18:17:21